Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010AJOG Global Reports at a Glance

• Egile Nagusiak: Devin Yu, PharmD (Egilea), Leona E. Ling, PhD (Egilea), Alexis A. Krumme, ScD (Egilea), May Lee Tjoa, PhD (Egilea), Kenneth J. Moise, Jr., MD (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2023-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is mediated by maternal alloantibodies, a consequence of immune sensitization during pregnancy with maternal-fetal incompatibility with ABO, Rhesus factor (Rh), and/or other red blood cell antigens. RhD, Kell, and other non-ABO alloantibo...